Featured News

Most of us have experienced the challenge of finding a public restroom, but for many, restroom access isn’t just a matter of convenience — it’s a serious medical issue.

The PROACTIVE Celiac Study is a phase 2 clinical trial testing the safety and effects of the investigational medication PRV-015.

If you have unexplained symptoms or have a family member with celiac disease, complete the Symptoms Assessment Tool to see if you have an increased risk for celiac disease – and receive a free product from CDF Proud Sponsor Schär. 

The need for action is clear. The failure to understand and treat celiac disease appropriately manifests in low rates of diagnosis, lack of research funding and alternative treatments, and limited understanding of the economic and social costs of this disease. 

Meet our runners for the 2022 TCS NYC Marathon!

Consider joining the LILY Study, a phase 1 clinical trial for people with celiac disease investigating DONQ52, a new potential celiac disease treatment.

Joining or creating a team for the Virtual Turkey Trot can boost your fundraising goals and accelerate the diagnosis and treatment of celiac disease.  

Listen in as Marilyn G. Geller, Chief Executive Officer of the Celiac Disease Foundation, talks with Mike and Cam at the Celiac Project Podcast about some of the exciting work we’re doing.

The Celiac Disease Foundation, the nation’s leading patient advocacy organization for celiac disease, announced today that Amanda Halligan has been named Director of Marketing and Communications.

Join Columbia University for an educational event on August 19th on the management of celiac disease after diagnosis. This is the second in a series of 10 bimonthly programs and is open to healthcare professionals and patients.